Zenas BioPharma, Inc. Payments of Stock Issuance Costs
Zenas BioPharma, Inc. (ZBIO) reported Payments of Stock Issuance Costs of $527.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- Zenas BioPharma, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $4.47M.
- Zenas BioPharma, Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $439.00K.
- Zenas BioPharma, Inc. payments of stock issuance costs for the quarter ending 2024-06-30 was $766.00K.
- Zenas BioPharma, Inc. payments of stock issuance costs for the quarter ending 2024-03-31 was $656.00K.
- Zenas BioPharma, Inc. payments of stock issuance costs for fiscal 2024 was $6.33M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $527.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $4.91M derived: sum of 2 quarters · filed 2025-11-12 | $5.68M derived: sum of 3 quarters · filed 2025-11-12 | $6.33M 10-K · filed 2025-03-11 |
| 2024-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.21M derived: sum of 2 quarters · filed 2025-11-12 | $1.86M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.42M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $656.00K 10-Q · filed 2025-05-15 |